Bertram Jacobs
Professor, School of Life Sciences
Professor, Biodesign Center for Personalized Diagnostics
Professor, Neurodegenerative Disease Associate Faculty
Professor, Biodesign Center for Mechanisms of Evolution
Professor, Mechanisms of Evolution Researchers
Professor, Neurodegenerative Disease Faculty
Professor, Center for Evolution and Medicine Affiliated Faculty
-
BDA 310C TEMPE, AZ 85287-5401
-
Mail code: 4501Campus: Tempe
-
Long Bio
Bertram Jacobs is a professor of virology with the School of Life Sciences. He is also a member of Biodesign Institute's Center for Immunotherapy, Vaccines and Virotherapy, where his research is focused on developing a vaccine for HIV — one that prevents infection or extends the lives of HIV patients. Jacobs also leads a group of students every summer to sub-Saharan Africa to teach AIDS prevention to the international community.
Jacobs is one of the world’s foremost experts on a poxvirus called vaccinia, a cousin of the smallpox virus. He has genetically engineered vaccinia as a vehicle against a number of infectious agents, bioterrorism threats, cancer, and other viruses, including HIV.
He also assists HIV/AIDS-related support organizations. He currently serves on the Board of Director’s for Aunt Rita’s Foundation, on the Advisory Board for Support for International Change, and on the Board of Directors for HEAL.
Education
- PhD Biochemistry, University of California-Berkeley 1981
- BS Biology, Rutgers University 1974
CV
Research Website URL
Publications
- Wellensiek BP, Larsen AC, Flores J, Jacobs BL, Chaput JC. A leader sequence capable of enhancing RNA expression and protein synthesis in mammalian cells. Protein Sci (2013).
- Wellensiek BP, Larsen AC, Stephens B, Kukurba K, Waern K, Briones N, Liu L, Snyder M, Jacobs BL, Kumar S, Chaput JC. Genome-wide profiling of human cap-independent translation-enhancing elements. Nature Methods (2013).
- Arndt W, Mitnik C, Denzler KL, White S, Waters R, Jacobs BL, Rochon Y, Olson VA, Damon IK, Langland JO. In vitro characterization of a nineteenth-century therapy for smallpox. PLoS One. 2012;7(3):e32610. doi: 10.1371 (2012).
- White SD, Jacobs BL. The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response. J. Virology (2012).
- Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques. Vaccine (2011).
- Denzler KL, Rice AD, MacNeill AL, Fukushima N, Lindsey SF, Wallace G, Burrage AM, Smith AJ, Manning BR, Swetnam DM, Gray SA, Moyer RW, Jacobs BL. The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus. Vaccine (2011).
- Denzler KL, Schriewer J, Parker S, Werner C, Hartzler H, Hembrador E, Huynh T, Holechek S, Buller RM, Jacobs BL. The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus. Vaccine (2011).
- Jancovich JK, Jacobs BL. Innate immune evasion mediated by the Ambystoma tigrinum virus eukaryotic translation initiation factor 2alpha homologue. J. Virology (2011).
- Kibler KV, Gomez CE, Perdiguero B, Wong S, Huynh T, Holechek S, Arndt W, Jimenez V, Gonzalez-Sanz R, Denzler K, Haddad EK, Wagner R, Sékaly RP, Tartaglia J, Pantaleo G, Jacobs BL, Esteban M. Improved NYVAC-based vaccine vectors. PLoS One (2011).
- White SD, Conwell K, Langland JO, Jacobs BL. Use of a negative selectable marker for rapid selection of recombinant vaccinia virus. Biotechniques (2011).
- Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR. Vaccinia virus vaccines: past, present and future. Antiviral Res (2009).
- Zhang P, Langland JO, Jacobs BL, Samuel CE. Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L. J Virol (2009).
- Y Ye, K Hauns, J Langland, Bertram Jacobs, B Hogue. Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein is a Type I Interferon Antagonist. J Virol (2007).
- J Langland, J Kash, V Carter, M Thomas, M Katze, Bertram Jacobs. Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins. J Virol (2006).
- Jeffrey Langland, Jason Cameron, Michael Heck, James Jancovich, Bertram Jacobs. Inhibition of PKR by RNA and DNA viruses. Virus Research (2006).
- Langland, J, Cameron, J, Heck, M, Jancovich, J, Jacobs, Bertram. Inhibition of PKR by RNA and DNA viruses. (2006).
- J Jancovich, E Davidson, N Parameswaran, J Mao, V Chinchar, J Collins, Bertram Jacobs, A Storfer. Evidence for emergence of an amphibian iridoviral disease because of human-enhanced spread. Mol Ecol (2005).
- T Brandt, M Heck, S Vijaysri, G Jentarra, J Cameron, Bertram Jacobs. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. Virology (2005).
- C Auch, R Saha, F Sheikh, X Liu, Bertram Jacobs, K Pahan. Role of protein kinase R in double-stranded RNA-induced expression of nitric oxide synthase in human astroglia. FEBS Lett (2004).
- J Langland, Bertram Jacobs. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. Virology (2004).
- K Kibler, A Miyazato, V Yedavalli, A Dayton, Bertram Jacobs, G Dapolito, S Kim, K Jeang. Polyarginine Inhibits gp160 Processing by Furin and Suppresses Productive Human Immunodeficiency Virus Type 1 Infection. J Biol Chem (2004).
- J Jancovich, J Collind, Bertram Jacobs, J Mao, V Chinchar, C Wyatt, S Case, Sudhir Kumar, G Valente, S Subramanian, E Davidson. Genomic Sequence of a Ranavirus (Family Iridoviridae) Associated with Salamander Mortalities in North America. Virology (2003).
- J Jancovich, James Collins, Bertram Jacobs, J Mao, V Chinchar, C Wyatt, S Case, S Kumar, G Valente, S Subramanian, E Davidson. Genomic sequence of a ranavirus (family Iridoviridae) associated with salamander mortalities in North America. Virology (2003).
- J Langland, P Kao, Bertram Jacobs. Regulation of IL-2 gene expression and nuclear factor-90 translocation in vaccinia virus-infected cells. J Interferon Cytokine Res (2003).
- S Vijaysri, L Talasela, A Mercer, C McInnes, Bertram Jacobs, J Langland. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo. Virology (2003).
- Y Kim, M Muralinath, T Brandt, M Pearcy, K Hauns, K Lowenhaupt, Bertram Jacobs, A Rich. A role for Z-DNA binding in vaccinia virus pathogenesis. Proc Natl Acad Sci U S A (2003).
- J Langland, Bertram Jacobs. The Role of the PKR-Inhibitory Genes, E3L and K3L, in Determining Vaccinia Virus Host Range. Virology (2002).
- Y He, H Nakao, S Tan, S Polyak, P Neddermann, S Vijaysri, Bertram Jacobs, M Katze. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol (2002).
- Y Xiang, R Condit, S Vijaysri, Bertram Jacobs, B Williams, R Silverman. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J Virol (2002).
- T Brandt, Bertram Jacobs. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol (2001).
- Y He, S Tan, S Tareen, Bertram Jacobs, S Vijaysri, J Langland, M Katze. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J Virol (2001).
Research Activity
- Jacobs,Bertram Lewis*, Kibler,Karen. A Novel Replication Competent Flavivirus-based HIV Vaccine Platform ie RepliVax as a Priming Component for Improving Antibody Response. CHUV(9/6/2012 - 8/31/2016).
- Jacobs,Bertram Lewis*, Kibler,Karen. dsRNA characterization in monkeypox-infected cells. HHS-NIH-NIAID(5/24/2012 - 4/30/2017).
- Denzler,Karen, Jacobs,Bertram Lewis, Langland,Jeffrey Olaf. Characterization of herbal formulations for the treatment of human disease. (3/1/2012 - 2/28/2013).
- Jacobs,Bertram Lewis*. XVII International Poxvirus, Asfivirus and Indorvirus Symposium. HHS-NIH-NIAID(6/2/2010 - 5/31/2011).
- Jacobs,Bertram Lewis*, Kibler,Karen. NYVAC Virus Constructs Expressing Mosaic HIV Envelope Proteins. IPPOX FDTN(1/1/2010 - 12/31/2010).
- Jacobs,Bertram Lewis*, Jacobs,Bertram Lewis*. Development of a Therapy for Smallpox Vaccinia and Monkeypox. MASSACHUSETTS INST OF TECHNOLO(8/1/2009 - 7/31/2011).
- Jacobs,Bertram Lewis*. Development of a novel, low-cost Point of Care HIV viral load diagnostic for resource-limited communities. NCIIA(4/1/2009 - 4/30/2010).
- Chaput,John C*, Jacobs,Bertram Lewis, Kumar,Sudhir. Discovering a Hidden Proteome in the Human Genome. HHS-NIH-NIGMS(8/1/2008 - 7/31/2013).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2008 - 12/31/2010).
- Jacobs,Bertram Lewis*. SUPP: Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2008 - 6/30/2009).
- Jacobs,Bertram Lewis*. Development of Poxvirus-Based Vectors as Vaccines Against Biodefense Threat Agents. PSWRCE(9/1/2007 - 4/30/2009).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2007 - 6/30/2010).
- Jacobs,Bertram Lewis*. SUPP: Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2007 - 6/30/2008).
- Jacobs,Bertram Lewis*. Development of a Safer Smallpox Vaccine. HHS-NIH-NIAID(4/1/2007 - 3/31/2010).
- Arntzen,Charles*, Jacobs,Bertram Lewis, Leket-Mor,Tsafrir Shlomo, Mason,Hugh S, Sierks,Michael Richard. BiaCore Instrument Purchase. HHS-NIH(3/1/2007 - 2/28/2009).
- Jacobs,Bertram Lewis*. Improving the immunogenicity of poxvirus based vectors. CHUV(8/1/2006 - 9/30/2015).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2006 - 6/30/2009).
- Jacobs,Bertram Lewis*. SUPP: Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/1/2006 - 6/30/2009).
- Jacobs,Bertram Lewis*. Development of a Safer Smallpox Vaccine. HHS-NIH-NIAID(4/1/2006 - 3/31/2008).
- Gonzalez,Julio Cesar*, Jacobs,Bertram Lewis. Mechanism of Vaccinia-Specific Cell Homing. HHS-NIH-NIAID(9/1/2005 - 9/30/2007).
- Jacobs,Bertram Lewis*, Chang,Yung. Disabling Vaccinia IFNr: A New Smallpox Vaccine. HHS-NIH-NIAID(7/10/2005 - 6/30/2006).
- Jacobs,Bertram Lewis*. DEVELOPMENT OF A SAFER SMALLPOX VACCINE. HHS-NIH-NIAID(4/1/2005 - 3/31/2007).
- Jacobs,Bertram Lewis*. Development of a Post-Exposure Vaccine for Smallpox. HHS-NIH-NIAID(3/15/2005 - 8/31/2007).
- Jacobs,Bertram Lewis*. Joint University Project #1638, Combinatorial Antibody Libraries of Orthopoxviruses. UNIV OF NEW MEXICO(1/1/2005 - 12/1/2009).
- Chang,Yung*, Brophy,Colleen M, Jacobs,Bertram Lewis, Misra,Rajeev, Pettit,George Robert, Sierks,Michael Richard, Zautra,Alex John. THE BD FACSARIA, A NEW FLOW CYTOMETER SORTER. HHS-NIH-NCRR(4/1/2004 - 3/31/2005).
- Jacobs,Bertram Lewis*. DEVELOPMENT OF A SAFER SMALLPOX VACCINE. HHS-NIH-NIAID(9/30/2003 - 3/31/2005).
- Dowling,Thomas Edmunds*, Bingham,Scott Edward, Blankenship,Robert E, Jacobs,Bertram Lewis, Wojciechowski,Martin Francis. A capillary DNA and denaturing HPLC for molecular genetics, ecogenomics, and experimental bioinformatics. NSF-BIO(9/1/2003 - 2/29/2008).
- Jacobs,Bertram Lewis*. Role of the E3L Gene in Poxvirus Pathogenesis. Continuation of LMS0010. HHS-NIH-NIAID(7/1/2003 - 12/31/2008).
- Jacobs,Bertram Lewis*. ROLE OF THE E3L GENE IN POXVIRUS PATHOGENESIS-Continued in JKS0033. HHS-NIH-NIAID(7/1/2003 - 12/31/2007).
- Davidson,Elizabeth W*, Collins,James, Jacobs,Bertram Lewis, Kumar,Sudhir, Roberson,Robert Wayne. EMERGING WILDLIFE DISEASES: THREATS TO AMPHIBIAN BIODIVERSITY. NSF-BIO(9/15/2002 - 2/28/2010).
- Jacobs,Bertram Lewis*. AN IMPROVED VACCINE FOR PROTECTION AGAINST SMALLPOX. HHS-NIH-NIAID(9/1/2002 - 8/31/2004).
- Jacobs,Bertram Lewis*. MUCOSAL IMMUNIZATION WITH A VACCINIA VIRUS-BASED VECTOR. HHS-NIH-NIAID(9/1/2002 - 8/31/2005).
- Jacobs,Bertram Lewis*. ROLE OF THE E3L GENE IN POXVIRUS PATHOGENESIS. HHS-NIH-NIAID(9/1/2002 - 8/31/2003).
- Gust,John Devens*, Arntzen,Charles, Bieber,Allan Leroy, Blankenship,Robert E, Brophy,Colleen M, Brune,Daniel Charles, Capco,David George, Chandler,Douglas E, Francisco,Wilson Alex, Hu,Qiang, Jacobs,Bertram Lewis, Leket-Mor,Tsafrir Shlomo, Lindsay,Stuart, Lorson,Christian L, Massia,Stephen Paul, Misra,Rajeev, Moore,Ana L, Moore,Thomas Andrew, Panitch,Alyssa, Sommerfeld,Milton R, Trelease,Richard Norman, Vermaas,Willem F J, Vernon,Brent, Williams,Peter, Woodbury,Neal Walter. PURCHASE OF A MALDI-TOF MASS SPECTROMETER. NSF-MPS(2/1/2002 - 1/31/2005).
- Jacobs,Bertram Lewis*. PATHOGENIC MECHANISMS IN POXVIRUSES. CHARLES A DANA FDN(10/1/2001 - 8/15/2009).
- Jacobs,Bertram Lewis*. PATHOGENIC MECHANISMS IN POXVIRUSES. CHARLES A DANA FDN(10/1/2001 - 9/30/2006).
- Jacobs,Bertram Lewis*. PATHOGENIC MECHANISMS IN POXVIRUSES. MASSACHUSETTS INST OF TECHNOLO(9/1/2001 - 8/31/2002).
- Jacobs,Bertram Lewis*. SPECIFIC INDUCTION OF DSRNA-MEDIATED SUICIDE IN LUNG CANCER CELLS. ABRC(7/1/2001 - 6/30/2002).
- Pizziconi,Vincent B*, Beaudoin,Diane Lynn, Capco,David George, Garcia,Antonio Agustin, Guilbeau,Eric J, He,Jiping, Jacobs,Bertram Lewis, Kipke,Daryl Richard, Sweeney,James David, Towe,Bruce C, Yamaguchi,Gary Tad. NEURAL MOLECULAR CELL TISSUE BIOENGINEERING: A THEME FOR THE NEW DEPARTMENT OF BIOENGINEERING AT ASU. WHITAKER FDN(7/1/2000 - 12/31/2015).
- Jacobs,Bertram Lewis*. VIRAL VECTORS FOR TREATMENT OF BRAIN CANCER. ABRC(7/1/2000 - 6/30/2001).
- Jacobs,Bertram Lewis*. SPECIFIC INDUCTION OF DSRNA-MEDIATED SUICIDE IN LUNG CANCER CELLS. ABRC(7/1/2000 - 6/30/2001).
- Jacobs,Bertram Lewis*. DEVELOPMENT OF VIRUSES TO TREAT CHEMOTHERAPY-RESISTANT CANCER Continuation of TDT8786. WALLACE FDN(1/1/2000 - 12/31/2006).
- Jacobs,Bertram Lewis*. DEVELOPMENT OF VIRUSES TO TREAT CHEMOTHERAPY-RESISTANT CANCER. WALLACE FDN(1/1/2000 - 12/31/2006).
- Guilbeau,Eric J*, Beaudoin,Diane Lynn, Capco,David George, Garcia,Antonio Agustin, He,Jiping, Jacobs,Bertram Lewis, Kipke,Daryl Richard, Pizziconi,Vincent B, Sweeney,James David, Towe,Bruce C, Yamaguchi,Gary Tad. NEURAL & MOLECULAR, CELL, & TISSUE BIOENGINEERING: A THEME FOR THE NEW DEPARTMENT OF BIOENGINEERING AT ASU. WHITAKER FDN(7/1/1999 - 6/30/2003).
- Jacobs,Bertram Lewis*, Bloom,David Clair. VIRAL VECTORS FOR TREATMENT OF BRAIN CANCER. ABRC(7/1/1999 - 6/30/2000).
- Jacobs,Bertram Lewis*. SPECIFIC INDUCTION OF DSRNA-MEDIATED SUICIDE IN LUNG CANCER CELLS. ABRC(7/1/1999 - 6/30/2000).
- Jacobs,Bertram Lewis*, Langland,Jeffrey Olaf. ASU BIOREACH. UNIV OF AZ(9/15/1998 - 12/31/2000).
- Jacobs,Bertram Lewis*. BORROW NEUROLOGICAL INSTITUTE. ST JOSEPH'S HOSPITAL & MED CTR(5/18/1998 - 5/18/2000).
- Jacobs,Bertram Lewis*. SUN HEALTH RESEARCH INSTITUTE FELLOWSHIP. SUN HEALTH RESEARCH INST(1/15/1998 - 12/31/2000).
- Jacobs,Bertram Lewis*. MECHANISMS OF TRANSFORMATION BY INHIBITORS OF THE INTERFERON SYSTEM. AMER CANCER SOCIETY (ACS)(7/1/1997 - 12/31/1998).
- Jacobs,Bertram Lewis*. SUN HEALTH RESEARCH INSTITUTE FELLOWSHIP. SUN HEALTH RESEARCH INST(9/1/1996 - 5/15/1998).
- Jacobs,Bertram Lewis*. REGULATION OF PROGRAMMED CELL DEATH IN HUMAN CANCER CELLS. ABRC(7/1/1996 - 6/30/1997).
- Jacobs,Bertram Lewis*. REGULATION OF PROGRAMMED CELL DEATH IN HUMAN CANCER CELLS. ABRC(7/1/1996 - 12/31/1998).
- Jacobs,Bertram Lewis*. REGULATION OF PROGRAMMED CELL DEATH IN HUMAN CANCER CELLS. ABRC(8/1/1995 - 6/30/1996).
- Jacobs,Bertram Lewis*. MECHANISM OF TRANSFORMATION BY INHIBITORS OF THE INTERFERON SYSTEM. AMER CANCER SOCIETY (ACS)(7/1/1995 - 6/30/1997).
- Jacobs,Bertram Lewis*. ROLE OF E3L IN POXVIRUS REPLICATION/IFN-RESISTANCE. HHS-NIH-NCI(2/1/1995 - 1/31/2000).
- Jacobs,Bertram Lewis*. MECHANISM OF ACTION OF INTERFERON AGAINST HIV. HHS-NIH-NIAID(4/1/1991 - 3/31/1995).
- Jacobs,Bertram Lewis*. CONTROL OF THE INTERFERON-INDUCED PROTEIN KINASE. HHS-NIH-NCI(5/1/1990 - 4/30/1993).
- Jacobs,Bertram Lewis*. SMALL INSTRUMENTATION PROGRAM. HHS(6/19/1989 - 5/31/1990).
- Jacobs,Bertram Lewis*. FIRST: CONTROL OF THE INTERFERON INDUCED PROTEIN KINASE. HHS(5/1/1989 - 4/30/1990).
- Jacobs,Bertram Lewis*. MECHANISM OF INDUCTION OF VIRUS-ASSOCIATED DIABETES MELLITUS. ABRC(7/1/1988 - 6/30/1990).
- Jacobs,Bertram Lewis*. CONTROL OF THE INTERFERON-INDUCED PROTEIN KINASE. HHS(5/1/1988 - 4/30/1989).
- Jacobs,Bertram Lewis*. MECHANISM OF INDUCTION OF VIRUS-ASSOCIATED DIABETES. ABRC(7/1/1987 - 6/30/1988).
- Jacobs,Bertram Lewis*. MECHANISM OF INDUCTION OF VIRUS-ASSOCIATED DIABETES MELLITUS. AMER DIABETES ASSN(7/1/1987 - 6/30/1990).
Courses
2023 Fall
| Course Number | Course Title |
|---|---|
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BDE 792 | Research |
| BIO 340 | General Genetics |
| MCB 500 | Research Methods |
| BIO 340 | General Genetics |
| BIO 340 | General Genetics |
| BIO 340 | General Genetics |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| BDE 799 | Dissertation |
| BIO 598 | Special Topics |
| MIC 598 | Special Topics |
| BIO 498 | Pro-Seminar |
| MCB 598 | Special Topics |
| MIC 498 | Pro-Seminar |
| BCH 598 | Special Topics |
| BCH 494 | Special Topics |
2023 Summer
| Course Number | Course Title |
|---|---|
| BDE 792 | Research |
| BIO 495 | Undergraduate Research |
| SSH 403 | Cross-Cultrl Studies Glbl Hlth |
2023 Spring
| Course Number | Course Title |
|---|---|
| BIO 493 | Honors Thesis |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| MIC 791 | Seminar |
| MCB 791 | Seminar |
| MCB 591 | Seminar |
| MIC 591 | Seminar |
| MBB 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| BIO 498 | Pro-Seminar |
| MIC 498 | Pro-Seminar |
| BDE 799 | Dissertation |
| BDE 792 | Research |
| BIO 498 | Pro-Seminar |
| BIO 498 | Pro-Seminar |
| BDE 795 | Continuing Registration |
| MIC 598 | Special Topics |
| BDE 799 | Dissertation |
2022 Fall
| Course Number | Course Title |
|---|---|
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BDE 792 | Research |
| BIO 340 | General Genetics |
| MCB 500 | Research Methods |
| BIO 340 | General Genetics |
| BIO 340 | General Genetics |
| BIO 340 | General Genetics |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| BDE 799 | Dissertation |
| BIO 340 | General Genetics |
2022 Summer
| Course Number | Course Title |
|---|---|
| BDE 792 | Research |
| BIO 495 | Undergraduate Research |
| SSH 403 | Cross-Culturl Stds Global Hlth |
| MIC 494 | Special Topics |
| BIO 494 | Special Topics |
2022 Spring
| Course Number | Course Title |
|---|---|
| BIO 493 | Honors Thesis |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| MIC 791 | Seminar |
| MCB 791 | Seminar |
| MCB 591 | Seminar |
| MIC 591 | Seminar |
| MBB 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| BIO 498 | Pro-Seminar |
| MIC 498 | Pro-Seminar |
| BDE 799 | Dissertation |
| BDE 792 | Research |
| BDE 792 | Research |
| BIO 498 | Pro-Seminar |
| BDE 795 | Continuing Registration |
| MIC 598 | Special Topics |
| BDE 799 | Dissertation |
2021 Fall
| Course Number | Course Title |
|---|---|
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BDE 792 | Research |
| MCB 500 | Research Methods |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| BDE 799 | Dissertation |
| BIO 598 | Special Topics |
| MIC 598 | Special Topics |
| BIO 498 | Pro-Seminar |
| BDE 799 | Dissertation |
2021 Summer
| Course Number | Course Title |
|---|---|
| BDE 792 | Research |
| BIO 495 | Undergraduate Research |
| SSH 403 | Cross-Culturl Stds Global Hlth |
| SSH 403 | Cross-Culturl Stds Global Hlth |
| MIC 494 | Special Topics |
2021 Spring
| Course Number | Course Title |
|---|---|
| BIO 493 | Honors Thesis |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| MIC 791 | Seminar |
| MCB 791 | Seminar |
| MCB 591 | Seminar |
| MIC 591 | Seminar |
| MBB 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| MIC 498 | Pro-Seminar |
| BDE 799 | Dissertation |
| BDE 792 | Research |
| BIO 498 | Pro-Seminar |
| BIO 498 | Pro-Seminar |
2020 Fall
| Course Number | Course Title |
|---|---|
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BDE 792 | Research |
| MCB 500 | Research Methods |
| MCB 591 | Seminar |
| MCB 791 | Seminar |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| BDE 799 | Dissertation |
2020 Summer
| Course Number | Course Title |
|---|---|
| BDE 792 | Research |
| BIO 495 | Undergraduate Research |
2020 Spring
| Course Number | Course Title |
|---|---|
| BIO 493 | Honors Thesis |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| MIC 791 | Seminar |
| MCB 791 | Seminar |
| MCB 591 | Seminar |
| MIC 591 | Seminar |
| MBB 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| MIC 498 | Pro-Seminar |
| BDE 799 | Dissertation |
| BDE 792 | Research |
| BIO 498 | Pro-Seminar |
2019 Fall
| Course Number | Course Title |
|---|---|
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BDE 792 | Research |
| MCB 500 | Research Methods |
| MCB 591 | Seminar |
| MCB 791 | Seminar |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| BDE 799 | Dissertation |
2019 Summer
| Course Number | Course Title |
|---|---|
| BDE 792 | Research |
| BIO 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| MIC 484 | Internship |
| BIO 484 | Internship |
2019 Spring
| Course Number | Course Title |
|---|---|
| BIO 493 | Honors Thesis |
| MIC 493 | Honors Thesis |
| MIC 495 | Undergraduate Research |
| MIC 791 | Seminar |
| MCB 791 | Seminar |
| MCB 591 | Seminar |
| MIC 591 | Seminar |
| MBB 495 | Undergraduate Research |
| BIO 495 | Undergraduate Research |
| BIO 498 | Pro-Seminar |
| MIC 498 | Pro-Seminar |
| BDE 799 | Dissertation |
| BDE 792 | Research |
2018 Fall
| Course Number | Course Title |
|---|---|
| BIO 492 | Honors Directed Study |
| MIC 495 | Undergraduate Research |
| BDE 792 | Research |
| MCB 500 | Research Methods |
| MCB 591 | Seminar |
| MCB 791 | Seminar |
| BIO 495 | Undergraduate Research |
| MBB 495 | Undergraduate Research |
| BDE 799 | Dissertation |
Presentations
- Karen Kibler, Shuk-Mei Lantzer, Garilyn Jentarra, Jeffrey Langland and Bert Jacobs. Replication-competent attenuated strains of vaccinia virus as potential HIV vaccine vectors. AIDS Vaccine 2009 (Oct 2009).
- William Arndt and Bert Jacobs. Interferon resistance of monkeypox virus. American Society for Virology Annual Meeting (Jun 2009).
- Susan Holechek. Post-exposure prophylaxis of poxvirus infections. American Society for Virology Annual meeting (Jun 2009).
- Jacobs, Bertram, Kibler, Karen. Replication competent, attenuated vaccine vectors. AIDS Vaccine Meetings (Oct 2008).
- Jancovich, James, Jacobs, Bertram. Ambystoma tigrinum virus. International Poxvirus Symposium (Jun 2008).
- Jacobs, Bertram. Replication competent, attenuated vaccine vectors. Keystone HIV vaccine meetings (Apr 2008).
- Jacobs, Bertram. Vaccines for Biodefense. Annual ASM Biodefense Meetings (Feb 2008).
- Jacobs, Bertram. Annual Meeting Arizona/Nevada Branch ASM (Feb 2003).
- Jacobs, Bertram. NIH Orthopoxvirus Research Group Meeting (May 2002).
- Jacobs, Bertram. Annual SIC Fundraiser - Keynote Speaker
- Jacobs, Bertram. Biophysics Chalk Talk
- Jacobs, Bertram. Body Positive
- Jacobs, Bertram. HIV in Service Training
- Jacobs, Bertram. Poxvirus Research Meeting
- Jacobs, Bertram. PVDC Site Visit
- Jacobs, Bertram. Science Cafe
- Jacobs, Bertram. SoLS Studio
- Jacobs, Bertram. University of California, Santa Barbara
Service
- NIH VirB Study Section, Ad hoc member (2014 - Present)
- Aunt Rita's Foundation, Board of Directors (2010 - Present)
- Aunt Rita's Foundation, Board of Directors (2010 - Present)
- Aunt Rita's Foundation, Board of Directors (2010 - Present)
- Journal of Virology, Editorial Board (2005 - Present)
- Journal of Virology, Editorial Board (2005 - Present)
- Board of Advisors, Support for International Change, Member (2005 - Present)
- Board of Advisors, Support for International Change, Member (2005 - Present)
- Board of Advisors, Support for International Change, Member (2005 - Present)
- Intellectual Property Committee, Member (2005 - Present)
- Intellectual Property Committee, Member (2005 - Present)
- Intellectual Property Committee, Member (2005 - Present)
- Intellectual Property Committee, Member (2005 - Present)
- Students for International Change, Faculty Advisor (2005 - Present)
- University Biosafety Committee, Chair (2005 - Present)
- University Biosafety Committee, Chair (2005 - Present)
- University Biosafety Committee, Chair (2005 - Present)
- University Biosafety Committee, Acting Chair (2005 - Present)
- SoLS, Interim Director (2014 - 2015)
- Journal of Virology, Editorial Board (2005 - 2011)
- Journal of Biological Chemistry, Editorial Board (2006 - 2011)
- Center for Infectious Diseases and Vaccinology, Biodesign Institute, Member (2006 - 2010)
- International Poxvirus Symposium, Organizer (2006 - 2010)
- SoLS, Biomedicine and Biotechnology Faculty Leader (2007 - 2010)
- HEAL, International, Member, Board of Directors (2008 - 2010)
- Intellectual Property Committee, Member (2005 - 2008)
- Students for International Change, Faculty Advisor (2005 - 2008)
- Students for International Change, Member, Board of Advisors (2005 - 2008)
- University Biosafety Committee, Mmeber (2005 - 2008)
- SoLS Facilities Committee, Member (2006 - 2007)
- NIH, Member, Virology A Study Section (2004 - 2007)
- Civilian Research Development Foundation, Consultant (2005 - 2005)
- Journal of Biological Chemistry, Ad hoc reviewer (2005 - 2005)
- Virology, Ad hoc reviewer (2005 - 2005)
- VATID Review Panel, NIH, Member (2004 - 2004)
- Poxvirus Proteomics Review Panel, NIH, Chair (2003 - 2003)
- ASU President's Community Enrichment Program, Journeys of the Mind, Speaker (2003)
- ASU Sigma Xi, Keynote Speaker (2003)
- AzBioDesign, Member (2003)
- Biochemistry, Ad hoc reviewer (2003)
- Civilian Research Development Foundation, Consultant (2003)
- Department of Microbiology, St. Louis University Medical School, Guest speaker (2003)
- Department of Microbiology, University of Mississippi Medical School, Guest speaker (2003)
- Intellectual Property Committee, Member (2003)
- Journal of Virology, Ad hoc reviewer (2003)
- NIH, Study Section member (2003)
- Radiation Protection Committee, Member (2003)
- University Biosafety Committee, Mmeber (2003)
- Virology, Ad hoc reviewer (2003)
- NIH Poxvirus Proteomics Review Panel, Member (2002 - 2002)
- NIH Experimental Virology Study Section, Ad hoc Member (2002 - 2002)
- NIH Rapid Response to Bioterrorism Study Section, Member (2002 - 2002)